| Tao, Rong |
NCT04004572: Sintilimab, Pegaspargase and Anlotinib for Stage IV Natural Killer /T-cell Lymphoma |
|
|
| Recruiting | 2 | 37 | RoW | LEAP regimen, Pegaspargase, Sintilimab, Anlotinib | Rong Tao | Natural Killer/T-Cell Lymphoma, Nasal and Nasal-Type | 12/21 | 12/22 | | |
NCT06314334: Screening Study of Combined Sequential Chemotherapy and Radiation Therapy for Early-stage NK/T-cell Lymphoma |
|
|
| Recruiting | 2 | 210 | RoW | Sintilimab+Pegaspargase, P-GemOx, GELAD, IMRT | Fudan University | Natural Killer/T-Cell Lymphoma, Nasal and Nasal-Type | 12/26 | 12/28 | | |
NCT06517511: Selinexor in Combination With R-CHOP as the First-line Therapy for TP53-mutated DLBCL Patients (Smart Trial) |
|
|
| Recruiting | 2 | 42 | RoW | Selinexor Oral Tablet [Xpovio], exportin 1 (XPO1) inhibitor, R-CHOP Protocol, R-CHOP regimen | Sun Yat-sen University, Fudan University | Diffuse Large B Cell Lymphoma | 01/26 | 04/28 | | |
NCT06519526: Exploratory Clinical Study of SHR-0302 and SHR-2554 in Patients With Relapsed/Refractory Peripheral T Cell Lymphoma |
|
|
| Recruiting | 2 | 25 | RoW | SHR-0302, SHR-2554 | Fudan University | Relapsed/Refractory Peripheral T Cell Lymphoma | 02/26 | 08/27 | | |
NCT06583837: Orelabrutinib Followed by Response-adapted Ultra-low Dose 4Gy Radiation as First-line Treatment of MALT Lymphoma |
|
|
| Recruiting | 2 | 50 | RoW | Orelabrutinib, response-adapted radiation, radiation | Fudan University | Lymphoma, B-Cell, Marginal Zone | 09/27 | 09/28 | | |
TOUCH, NCT04425070: A Study of Evaluating the Safety and Efficacy of ATG-010 Combined With Chemotherapy Sequential With ATG-010 Monotherapy Maintenance in Peripheral T- and NK/T-cell Lymphoma |
|
|
| Active, not recruiting | 1/2 | 56 | RoW | ICE [ifosfamide+carboplatin+etoposide], GEMOX [gemcitabine+oxaliplatin], Tislelizumab | Antengene Corporation | Peripheral T-cell Lymphoma, NK/T-cell Lymphoma | 12/24 | 12/24 | | |
|
|
|
NCT05577364: Selinexor in Combination With R-CHOP Followed by Selinexor Maintenance for Untreated EBV-positive DLBCL Patients |
|
|
| Recruiting | 1/2 | 54 | RoW | Selinexor, exportin 1 (XPO1) inhibitor, R-CHOP Protocol, Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, Prednisone | Sun Yat-sen University, Fudan University, Antengene Corporation | EBV-Positive Diffuse Large B-Cell Lymphoma, Nos | 12/24 | 02/26 | | |
NCT05186012: APG-1252 Monotherapy or in Combination With Other Therapeutic Agent in Subjects With Relapsed or Refractory Non-Hodgkin Lymphoma |
|
|
| Recruiting | 1/2 | 51 | RoW | APG-1252, Pelcitoclax, Chidamide | Ascentage Pharma Group Inc. | NHL, Adult | 09/25 | 03/26 | | |
TEACH, NCT04281420: A Study of Evaluating Dual Inhibitor of PAK4 and NAMPT ATG-019 in Advanced Solid Tumors or Non-Hodgkin's Lymphoma |
|
|
| Terminated | 1 | 20 | RoW | ATG-019, KPT-9274, ATG-019 + Niacin ER | Antengene Therapeutics Limited | Solid Tumor, Non-Hodgkin's Lymphoma | 10/23 | 10/23 | | |
| Recruiting | 1 | 48 | RoW | KQ-2002 CAR-T cells （CD19/CD22 CAR T-Cells） | Rong Tao, Novatim Immune Therapeutics (Zhejiang) Co., Ltd. | Acute Lymphoblastic Leukemia, in Relapse, Acute Lymphoblastic Leukemia With Failed Remission, B-cell Lymphoma Refractory, B-cell Lymphoma Recurrent | 10/26 | 12/26 | | |
NCT06517004: An Open-label, Single-arm Study of JWCAR201 in the Treatment of Relapsed or Refractory Diffuse Large B-cell Lymphoma |
|
|
| Recruiting | 1 | 9 | RoW | JWCAR201 | Fudan University | Diffuse Large B Cell Lymphoma | 12/25 | 08/27 | | |
NCT04366128: Camrelizumab, Pegaspargase and Apatinib With Radiation Therapy for Stage IE/IIE ENKTL |
|
|
| Recruiting | N/A | 60 | RoW | CAPA indution immunotherapy, Radiotherapy | Rong Tao | Natural Killer/T-Cell Lymphoma, Nasal and Nasal-Type | 12/21 | 12/23 | | |
NCT05058755: Tislelizumab Combined Treatment in Refractory Extranodal NK/T-cell Lymphoma |
|
|
| Completed | N/A | 62 | RoW | tislelizumab, azacytidine, lenalidomide, Tileilizhu Dankang, tislelizumab, etoposide, pegaspargase | Xinhua Hospital, Shanghai Jiao Tong University School of Medicine | Natural Killer/T-Cell Lymphoma, Nasal and Nasal-Type | 12/22 | 12/23 | | |
| Recruiting | N/A | 2500 | RoW | patients receive optimal treatment or follow-up according to the characteristics of the disease | Fudan University | Marginal Zone Lymphoma | 06/29 | 06/34 | | |
NCT02776384: Prognostic and Diagnostic Value of Biomarkers and Cardiac Functional Parameters in Patients With Chronic Heart Failure |
|
|
| Recruiting | N/A | 1000 | RoW | Observational study, no intervention | Shanghai Jiao Tong University School of Medicine | Chronic Heart Failure | 12/25 | | | |
| Sun, Kun |
NCT04307030: Study on AI Recognition System Of Heart Sound In Congenital Heart Disease Screening |
|
|
| Recruiting | N/A | 5000 | RoW | Heart Auscultation and Echocardiography | Xinhua Hospital, Shanghai Jiao Tong University School of Medicine | Congenital Heart Disease in Children | 12/21 | 06/23 | | |
NCT06191354: A Clinical Study Evaluating the Safety and Efficacy of SKG0201 Injection in Patients With Spinal Muscular Atrophy Type 1 |
|
|
| Recruiting | N/A | 12 | RoW | SKG0201 Injection, SKG0201 | Kun Sun | Spinal Muscular Atrophy 1 | 06/25 | 12/25 | | |
NCT04522011: Comparison of the Efficiency Between Intraoperative and Postoperative Hyperthermic Intraperitoneal Chemotherapy With Docetaxel Combine Oxaliplatin in Patients With Advanced Gastric Cancer |
|
|
| Not yet recruiting | N/A | 200 | RoW | intraoperative or postoperative hyperthermic intraperitoneal chemotherapy | First Affiliated Hospital Xi'an Jiaotong University | Stomach Neoplasms, Hyperthermic Intraperitoneal Chemotherapy | 02/23 | 02/23 | | |
| Sun, Xin |
NCT03712969: Shenlingcao Oral Liquid for Patients With Stage II or IIIA NSCLC |
|
|
| Completed | 4 | 527 | RoW | Shenlingcao Oral Liquid | West China Hospital | Carcinoma, Non-Small-Cell Lung, Chemotherapy, Adjuvant | 03/22 | 05/23 | | |
NCT04953741: A Comparative Study on the Efficacy of Different Stepping-down Therapy for Childhood Asthma |
|
|
| Not yet recruiting | 4 | 90 | RoW | Fluticasone propionate inhaled aerosol | Xijing Hospital | Asthma in Children | 08/22 | 08/22 | | |
NCT05092841: A Study to Assess the Efficacy and Safety of PXT3003 in Charcot-Marie-Tooth Type 1A |
|
|
| Completed | 3 | 176 | RoW | PXT3003, (RS)-baclofen, naltrexone hydrochloride and D-sorbitol oral fixed dose combination, PXT3003 placebo, liquid oral solution | Tasly GeneNet Pharmaceuticals Co., Ltd | Charcot-Marie-Tooth Type 1A | 03/24 | 03/24 | | |
| Recruiting | 2 | 50 | RoW | Trilaciclib, Cosela, Pirarubicin, Lobaplatin | Peking University People's Hospital | Osteosarcoma | 07/25 | 11/25 | | |
NCT05944224: A Study to Efficacy and Safety of SPH4336 Monotherapy or in Combination With Cadonilimab in Patients With Advanced Solid Tumors. |
|
|
| Recruiting | 1/2 | 63 | RoW | SPH4336, Cadonilimab | Shanghai Pharmaceuticals Holding Co., Ltd | Advanced Solid Tumors | 05/25 | 12/25 | | |
NCT06415071: Hypertension Longitudinal Data Platform in Tianjin |
|
|
| Completed | N/A | 1172280 | RoW | No intervention | West China Hospital, Tianjin Health Care Big Data Ltd., Tianjin Health Commission | Hypertension | 12/21 | 12/21 | | |
NCT04222621: Xiamen Registry of Pregnant Women and Offspring (REPRESENT) |
|
|
| Active, not recruiting | N/A | 761194 | NA | Pregnant women without intervention | West China Hospital, Xiamen Health and Medical Big Data Center, Xiamen Health Commission | Pregnant Women, Registries | 03/19 | 12/23 | | |
NCT03958760: Characteristics, Treatment, and Economic Burden of Patients With CVD,CKD or at High Cardiovascular Risk |
|
|
| Completed | N/A | 200000 | RoW | | West China Hospital | Cardiovascular Abnormalities, Chronic Kidney Diseases, Diabetes | 10/21 | 12/21 | | |
NCT04658992: The Registration on the Use of Feilike Heji in Minors |
|
|
| Recruiting | N/A | 3000 | RoW | | China Academy of Chinese Medical Sciences | Bronchial Asthma | 12/21 | 03/22 | | |
RESERVE, NCT04861389: Distal Transradial Access for Primary Percutaneous Coronary Intervention in STEMI Patients |
|
|
| Recruiting | N/A | 414 | RoW | Arterial access | Shenzhen People's Hospital | Acute ST-segment Elevation Myocardial Infarction, Radial Artery Occlusion, Distal Radial Artery Approach | 12/21 | 01/22 | | |
NCT06048276: Miscarriage Preventing Herbal Medicines and the Risk of Birth Defects: a Population-based Cohort Study |
|
|
| Active, not recruiting | N/A | 200000 | RoW | Herbal medicines (e.g., Yunkang granules, Duzhong granules) | West China Hospital, Xiamen Health Commission, Xiamen Health and Medical Big Data Center | Pregnancy, Birth Defects, Drug Exposures | 10/24 | 12/24 | | |
NCT06180447: Peri-conceptional or Pregnancy Exposure of Vaccination and the Risk of Adverse Pregnancy Outcomes |
|
|
| Active, not recruiting | N/A | 150000 | RoW | Hepatitis B vaccine, rabies vaccine, HPV vaccine, influenza vaccine | Sun Xin | Vaccine Adverse Reaction | 12/24 | 03/25 | | |
NCT06770465: Maternal Use of Antibiotics and the Risk of Congenital Malformations |
|
|
| Active, not recruiting | N/A | 850000 | RoW | Different categories of antibiotics | West China Hospital | Congenital Malformations | 06/25 | 06/26 | | |
| Not yet recruiting | N/A | 1435 | NA | | Xinhua Hospital, Shanghai Jiao Tong University School of Medicine | Child Development | 07/29 | 07/30 | | |
NCT06542120: Research on Body Voice AI Recognition System for Children's Health Management |
|
|
| Not yet recruiting | N/A | 30000 | RoW | Heart Auscultation and Echocardiography, Chest Auscultation and Chest imaging examinations, Abdominal Auscultation and Abdominal imaging examinations | Xinhua Hospital, Shanghai Jiao Tong University School of Medicine | Congenital Heart Disease, Bronchopneumonia, Abdominal Disease | 07/25 | 12/25 | | |
PSAKOA, NCT06675981: Placebo Response of Different Types of Sham Acupuncture for Knee Osteoarthritis |
|
|
| Not yet recruiting | N/A | 150 | RoW | Real Acupuncture, Non-acupuncture at real-acupoint, Shallow acupuncture at real-acupoint, Shallow acupuncture at non-meridian and non-acupoint | West China Hospital | Knee Osteoarthritis | 04/25 | 04/25 | | |
| Recruiting | N/A | 4500 | RoW | | Xinhua Hospital, Shanghai Jiao Tong University School of Medicine | Sepsis | 03/21 | 04/21 | | |
| Recruiting | N/A | 200 | RoW | | Shenzhen People's Hospital | Coronary Syndrome | 06/21 | 07/21 | | |
NCT05454397: A Study on the Status of Nutritional Risk Screening and Nutritional Therapy in Neurology Hospitalized Stroke Patients |
|
|
| Recruiting | N/A | 2000 | RoW | Observational study, no intervention | Nanfang Hospital of Southern Medical University, First Affiliated Hospital of Fujian Medical University, Yantai Yuhuangding Hospital, The First Hospital of Jilin University, Qilu Hospital of Shandong University, ZHEJIANG PROVINCE XIAOSHAN HOSPITAL, The First People's Hospital of Wenling, Ganzhou People's Hospital, Affiliated Hospital of Jining Medical hospital, Henan Provincial People's Hospital, Zhongda Hospital Southeast University, The Second Affiliated Hospital of Harbin Medical University, The First people's Hospital of Kunshan, The 2nd Affiliated Hospital of Wenzhou Medical University, THE FIRST PEOPLE'S HOSPITAL OF JIASHAN, The First Affiliated Hospital of Xi'an Jiaotong University Medical College, Fujian Province Zhangzhou Hospital, People's Hospital of Chongqing, Nanjing Zijin Hospital, Hangzhou Red Cross Hospital, Wenzhou Hospital of Chinese Medicine, Kaifeng Central Hospital, First Affiliated Hospital of Guangxi Medical University, Zhongshan Hospital of Xiamen University, Xi'an Encephalopathy of Traditional Chinese Medicine Hospital, 903 Hospital of the Chinese People's Liberation Army Joint Logistics and Security Forces, Xiangya Hospital of Central South University, Second Affiliated Hospital of Suzhou University, Tongji Hospital, The Affiliated Hospital o fQingdao University, The First Affiliated Hospital of Anhui Medical University, Yancheng Third People's Hospital, Linyi People's Hospital, Dongfang Hospital of Beijing University of Chinese Medicine, Affiliated Hospital of Qingdao University | Acute Stroke | 10/22 | 10/23 | | |
| Liu, Chuanxu |
NCT06314334: Screening Study of Combined Sequential Chemotherapy and Radiation Therapy for Early-stage NK/T-cell Lymphoma |
|
|
| Recruiting | 2 | 210 | RoW | Sintilimab+Pegaspargase, P-GemOx, GELAD, IMRT | Fudan University | Natural Killer/T-Cell Lymphoma, Nasal and Nasal-Type | 12/26 | 12/28 | | |
NCT06519526: Exploratory Clinical Study of SHR-0302 and SHR-2554 in Patients With Relapsed/Refractory Peripheral T Cell Lymphoma |
|
|
| Recruiting | 2 | 25 | RoW | SHR-0302, SHR-2554 | Fudan University | Relapsed/Refractory Peripheral T Cell Lymphoma | 02/26 | 08/27 | | |
NCT06517004: An Open-label, Single-arm Study of JWCAR201 in the Treatment of Relapsed or Refractory Diffuse Large B-cell Lymphoma |
|
|
| Recruiting | 1 | 9 | RoW | JWCAR201 | Fudan University | Diffuse Large B Cell Lymphoma | 12/25 | 08/27 | | |
NCT05058755: Tislelizumab Combined Treatment in Refractory Extranodal NK/T-cell Lymphoma |
|
|
| Completed | N/A | 62 | RoW | tislelizumab, azacytidine, lenalidomide, Tileilizhu Dankang, tislelizumab, etoposide, pegaspargase | Xinhua Hospital, Shanghai Jiao Tong University School of Medicine | Natural Killer/T-Cell Lymphoma, Nasal and Nasal-Type | 12/22 | 12/23 | | |
NCT04837222: A Study of Brentuximab Vedotin in Adults With CD30-positive Lymphoma |
|
|
| Active, not recruiting | N/A | 1000 | RoW | No Intervention | Takeda | Lymphoma | 06/26 | 06/26 | | |
